Footwear retailer Shoe Carnival (NASDAQ:SCVL) in Q1 CY2025, with sales falling 7.5% year on year to $277.7 million. On the other hand, the company’s full-year revenue guidance of $1.19 billion at the ...

Shoe Carnival, Inc. SCVL reported third-quarter fiscal 2024 results, wherein the top line lagged the Zacks Consensus Estimate and bottom line surpassed the same. Both metrics declined year over year.

Shoe Carnival’s Q3 EPS of 71 cents beat estimates, while sales of $306.9M missed consensus due to a retail calendar shift. Shoe Carnival lowers FY24 sales outlook to $1.20B-$1.23B, but maintains ...

CEO Mark Worden opened the call stating that "the company's first quarter 2025 results were better than expected, with profits outperforming expectations by approximately 10%, our rebanner expansion ...

The Company's Shoe Carnival banner contributed a net sales decline of 10.0 percent. First quarter 2025 net sales from Rogan's, which was acquired on February 13, 2024, were in-line with integration ...

Shoe Carnival posted lower fiscal second-quarter sales and cut its full-year sales outlook as pressure on the low-income consumer hurt its namesake shoe brand. The footwear retailer on Thursday said ...

Mark Worden, President and CEO, highlighted that "Our second quarter results demonstrate meaningful progress on our corporate strategy. We beat earnings consensus by over 20% and expanded gross ...

Shoe Carnival, Inc. (NASDAQ:SCVL) shares surged Thursday after the company reported its second-quarter results. The company reported second-quarter adjusted earnings per share of 91 cents, beating the ...

Shoe Carnival’s Shoe Perks loyalty program earns members points on every purchase they make in-store and online. Points earn rewards and never expire. Members get free in-store pickup, free shipping, ...

Shoe Carnival, Inc. (Nasdaq: SCVL) (the “Company”), a leading retailer of footwear and accessories for the family, today reported results for the second quarter ended August 2, 2025 and updated its ...

Management reaffirmed annual fiscal 2025 guidance for net sales of $1.15 billion to $1.23 billion, GAAP EPS in a range of $1.60 to $2.10, gross profit margins of 35% to 36%, SG&A between $350 million ...